 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
2-12-2024
Insider Buy |
Samsara BioCapital GP, LLC
|
$13.50
CAGR »
|
$7,499,992.50
555,555 shares |
9-6-2023
Insider Buy |
Jon Congleton
Chief Executive Officer |
$12.08
CAGR »
|
$27,180.00
2,250 shares |
8-11-2023
Insider Buy |
Jon Congleton
Chief Executive Officer |
$12.89
CAGR »
|
$25,780.00
2,000 shares |
2-14-2023
Insider Buy |
Healthcare Investments (cayman) LTD. Hbm
>10% Owner |
$16.00
CAGR »
|
$5,000,000.00
312,500 shares |
2-14-2023
Insider Buy |
Brian Taylor Slingsby
Director and >10% Owner |
$16.00
CAGR »
|
$4,000,000.00
250,000 shares |
2-14-2023
Insider Buy |
Srinivas Akkaraju
Director and >10% Owner |
$16.00
CAGR »
|
$15,000,000.00
937,500 shares |
2-14-2023
Insider Buy |
Adam Scott Levy
CFO, Chief Bus. Off. and Secy. |
$16.00
CAGR »
|
$100,000.00
6,250 shares |
Also See: Institutional Holders of MLYS
Also See: SEC filings
Below we present the annualized performance delivered by MLYS stock since 2-12-2024 (the date of the most recent
insider purchase). The performance of the investment from the time MLYS insider buying occurred is the ultimate
test of whether insiders were right about MLYS being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/13/2024 |
|
| End date: |
04/30/2024 |
|
| Start price/share: |
$14.25 |
|
| End price/share: |
$12.25 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-14.04% |
|
| Annualized Gain: |
-67.41% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,596.00 |
|
| Years: |
0.21 |
|
MLYS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent MLYS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding MLYS
|
|
Free MLYS Email Alerts:
